Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Athena Technology Acquisition (ATEK) Competitors

Athena Technology Acquisition logo

ATEK vs. CRTX, OMCL, HSTM, MDRX, SIMA, HOND, GCL, POLE, JACS, and VCIC

Should you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), SIM Acquisition Corp. I (SIMA), HCM II Acquisition (HOND), GCL Global (GCL), Andretti Acquisition Corp. II (POLE), Jackson Acquisition Co II (JACS), and Vine Hill Capital Investment (VCIC).

Athena Technology Acquisition vs.

Cortexyme (NASDAQ:CRTX) and Athena Technology Acquisition (NYSE:ATEK) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, community ranking, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CortexymeN/AN/A-$89.94M-$2.97-0.36
Athena Technology AcquisitionN/AN/AN/AN/AN/A

In the previous week, Athena Technology Acquisition's average media sentiment score of 0.34 beat Cortexyme's score of 0.00 indicating that Athena Technology Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
Cortexyme Neutral
Athena Technology Acquisition Neutral

Athena Technology Acquisition received 478 more outperform votes than Cortexyme when rated by MarketBeat users. However, 64.44% of users gave Cortexyme an outperform vote while only 63.65% of users gave Athena Technology Acquisition an outperform vote.

CompanyUnderperformOutperform
CortexymeOutperform Votes
154
64.44%
Underperform Votes
85
35.56%
Athena Technology AcquisitionOutperform Votes
632
63.65%
Underperform Votes
361
36.35%

Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.

Company Net Margins Return on Equity Return on Assets
CortexymeN/A -70.96% -63.53%
Athena Technology Acquisition N/A N/A N/A

Cortexyme has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Athena Technology Acquisition has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500.

63.2% of Cortexyme shares are held by institutional investors. Comparatively, 17.3% of Athena Technology Acquisition shares are held by institutional investors. 27.9% of Cortexyme shares are held by insiders. Comparatively, 88.4% of Athena Technology Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Athena Technology Acquisition beats Cortexyme on 5 of the 8 factors compared between the two stocks.

Get Athena Technology Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEK vs. The Competition

MetricAthena Technology AcquisitionHolding Offices Industry SectorNYSE Exchange
Market Cap$81.20M$473.41M$2.46B$19.21B
Dividend YieldN/A7.74%13.16%4.00%
P/E RatioN/A2.4110.8833.45
Price / SalesN/A54.323,410,846.7229.18
Price / CashN/A69.0154.9917.52
Price / BookN/A3.663.144.55
Net IncomeN/A$35.22M-$305.73M$1.02B

Athena Technology Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATEK
Athena Technology Acquisition
N/A$8.00
flat
N/AN/A$81.20MN/A0.002,021
CRTX
Cortexyme
N/A$1.10
-2.7%
N/A+12.5%$33.17MN/A-0.3755
OMCL
Omnicell
2.1715 of 5 stars
$31.37
+0.4%
$50.67
+61.5%
+6.4%$1.47B$1.11B116.303,800Upcoming Earnings
Analyst Downgrade
News Coverage
Positive News
HSTM
HealthStream
3.8235 of 5 stars
$33.57
-0.2%
$32.00
-4.7%
+26.1%$1.02B$291.65M51.641,140Upcoming Earnings
Positive News
MDRX
Veradigm
2.8366 of 5 stars
$4.30
+1.2%
$14.00
+225.6%
-43.6%$465.54M$1.53B0.008,000
SIMA
SIM Acquisition Corp. I
N/A$10.26
+0.1%
N/AN/A$314.64MN/A0.00N/ANews Coverage
HOND
HCM II Acquisition
N/A$10.90
flat
N/AN/A$313.38MN/A0.00N/ANews Coverage
Positive News
GCL
GCL Global
N/A$2.40
flat
N/AN/A$303.06M$112.35M0.00N/A
POLE
Andretti Acquisition Corp. II
N/A$10.22
flat
N/AN/A$301.59MN/A0.00N/ANews Coverage
Positive News
JACS
Jackson Acquisition Co II
N/A$10.17
+0.2%
N/AN/A$300.93MN/A0.002
VCIC
Vine Hill Capital Investment
N/A$10.25
+0.3%
N/AN/A$300.66MN/A0.00N/ANews Coverage
Positive News
Gap Up
High Trading Volume

Related Companies and Tools


This page (NYSE:ATEK) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners